Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × pegfilgrastim × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 6 Breast Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Rhabdomyosarcoma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Burkitt Lymphoma 3 Triple Negative Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Pain 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Multiple Myeloma 1 Medulloblastoma 1

Interventions

Cyclophosphamide 46 fludarabine 29 Rituximab 28 Doxorubicin 13 Prednisone 12 Magnetic Resonance Spectroscopy 12 fludarabine phosphate 11 Vincristine 11 Specimen Handling 11 Bendamustine Hydrochloride 10 pirtobrutinib 9 Lenalidomide 9 Etoposide 9 Biopsy 8 pembrolizumab 7 obinutuzumab 7 zanubrutinib 6 venetoclax 6 polatuzumab vedotin 5 glofitamab 5 Leukapheresis 5 Immunotherapy, Adoptive 5 tazemetostat 4 tafasitamab 4 ibrutinib 4 etoposide phosphate 4 Nivolumab 4 Injections 4 CT-P10 4 loncastuximab tesirine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡